intestine is normal with no evidence of malabsorption." Three-day faecal fat excretion and xylose absorption test were normal.
Although the serum B12 level was not available at the time, the evidence from blood, marrow, and barium meal examinations suggested vitamin B12 deficiency due to pernicious anaemia, and treatment was started with hydroxocobalamin 1 mg intramuscularly daily for four days, and then weekly. There was no haematological reponse, and the haemoglobin fell further to 34 %. The patient was then admitted to the Luton and Dunstable Hospital (under Dr B P Harrold), where folic acid was added to her treatment, again with no response in the peripheral blood or marrow. A blood transfusion brought her haemoglobin up to 10-8 g/dl, but a subsequent marrow aspiration confirmed the previous findings of a megaloblastic picture, with a few ring sideroblasts, insufficient to justify a diagnosis of sideroblastic anaemia. At the suggestion of the haematologist (Dr J R B Williams) a therapeutic trial of pyridoxine was begun with a dose of 50 mg twice a day. Seven days later the marrow had reverted to normal and the patient was discharged on pyridoxine alone. In the following weeks her haemoglobin gradually returned to normal levels. After the diagnosis had been established the serum B12 level, in a sample of blood taken at the start of the investigation and before the administration of hydroxocobalamin, was reported as normal at 360 ng/l. A Schilling test was also normal.
Comment
Administration of combined oestrogen-progestogen oral contraceptive agents (OCA) can lead to a disturbance of tryptophan and vitamin B6 metabolism owing to the oestrogen component causing induction of tryptophan oxygenase in the liver. This causes increased metabolism of tryptophan and hence an increased need for the necessary coenzyme pyridoxal phosphate.1 Boots et al2 report that a tenfold or greater increase in vitamin B6 requirements is necessary to compensate for this effect. Rose et al3 reported that a subclinical vitamin B6 deficiency may result, and Adams et al4 reported that a form of depression found in OCA users responds to pyridoxine administration. Brown et al5 concluded that a small subgroup of women may exist who are particularly vulnerable to vitamin B6 deficiency when taking OCA, but I can find no previous reports of megaloblastic anaemia associated with OCA usage in a patient wi;h no other apparent cause and responding to vitamin B6 administration. I suggest that the above patient represents such a case. Serum prolactin and GH concentrations are shown in the figure. The difference between resting levels in the three groups is not significant but the peroperative levels are statistically significantly different from each other and from the resting levels (P = < 0-025 Mann-Witney U Test). Prolactin concentrations rose within 15 minutes and remained high for up to one hour, by which time most operations in this series were completed. The readings shown in the figure are from samples taken between 15 and 30 minutes after induction. The removal of a lump in the breast was for a benign lesion in five cases and for a malignant tumour in four. The mean peroperative level for the benign group was 71 ± 8-4 ,Lg/l (standard error of the mean) and for the malignant group 124±13-5 ,ug 
Discussion
There is little published data on prolactin concentrations during anaesthesia in man. One study shows a significant rise in both men and women, with a greater rise in women.' We have found a significant rise in all groups studied but of special interest is the finding of much higher concentrations in women undergoing surgery for a lump in the breast. The women with malignant lumps seem to have the highest concentrations, but the numbers are too small to draw definite conclusions. Abnormalities in basal prolactin concentrations have been reported in some women with benign and malignant breast lumps.2-4 A small difference in peak prolactin response to TRH has been claimed in advanced breast cancer compared with earlier stages and with normal people.5
Whether these differences are due to inherent differences in prolactin secretion or to greater stress in women with breast lumps is not clear. The failure of growth hormone concentrations to rise significantly is against the latter explanation.
